Direct acquisition; Oligonucleotides for PCR (primers and probes)

Sammendrag

Helse Bergen HF and with options for Helse Stavanger HF and Helse Førde HF has the intention to enter framework agreements with two vendors, TIB Molbiol Syntheselabor GmbH and Life Technologies AS for Oligonucleotides for PCR (primers and probes) on behalf of the department of Microbiology. The oligonucleotides are to be used for an in-house respiratory PCR panel.For more detailed information please see the attached document "Justification for direct acquisition with notification of intent".